cd19 car-t expressing il7 and ccl19
Primary Mediastinal Large B-cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityCell therapyDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
87 Active assets in the Primary Mediastinal Large B-cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ifosfamide David Bond, MD | Phase 4 | BBB |
Inno-206 Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Phase 4 | BBB |
ETOPOSIDE University of Washington | Phase 4 | BBB |
ETOPOSIDE University of Washington | Phase 4 | BBB |
Inno-206 University of Washington | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
cd19 car-t expressing il7 and ccl19 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →